OncoTherapy Science, Inc. (4564.T)

JPY 23.0

(-4.17%)

Long Term Debt Summary of OncoTherapy Science, Inc.

  • OncoTherapy Science, Inc.'s latest annual long term debt in 2023 was 106.84 Million JPY , down 0.0% from previous year.
  • OncoTherapy Science, Inc.'s latest quarterly long term debt in 2024 Q1 was 92.95 Million JPY , down -13.0% from previous quarter.
  • OncoTherapy Science, Inc. reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • OncoTherapy Science, Inc. reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • OncoTherapy Science, Inc. reported quarterly long term debt of - JPY for 2023 Q3, down 0.0% from previous quarter.
  • OncoTherapy Science, Inc. reported quarterly long term debt of 106.84 Million JPY for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of OncoTherapy Science, Inc. (2023 - 2004)

Historical Annual Long Term Debt of OncoTherapy Science, Inc. (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 106.84 Million JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%
2010 - JPY 0.0%
2009 - JPY 0.0%
2008 - JPY -100.0%
2007 111.05 Million JPY 0.0%
2006 - JPY 0.0%
2005 - JPY 0.0%
2004 - JPY 0.0%

Peer Long Term Debt Comparison of OncoTherapy Science, Inc.

Name Long Term Debt Long Term Debt Difference
KOHJIN BIO CO LTD 767.03 Million JPY 86.07%
PRISM BioLab Co.,LTD - JPY -Infinity%
GNI Group Ltd. 2 Billion JPY 94.658%
Linical Co., Ltd. 1.49 Billion JPY 92.876%
Trans Genic Inc. 1.32 Billion JPY 91.949%
MEDINET Co., Ltd. 781 Thousand JPY -13581.05%
Soiken Holdings Inc. - JPY -Infinity%
Cytori Cell Research Institute, Inc. 2.34 Billion JPY 95.448%
AnGes, Inc. 214.94 Million JPY 50.291%
Nxera Pharma Co., Ltd. 63.21 Billion JPY 99.831%
Immuno-Biological Laboratories Co., Ltd. 84.56 Million JPY -26.357%
NanoCarrier Co., Ltd. 1.1 Billion JPY 90.365%
Carna Biosciences, Inc. 28.4 Million JPY -276.202%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 875.59 Million JPY 87.797%
RaQualia Pharma Inc. 39.05 Million JPY -173.621%
Chiome Bioscience Inc. - JPY -Infinity%
Kidswell Bio Corporation 1.83 Billion JPY 94.187%
PeptiDream Inc. 19.63 Billion JPY 99.456%
Oncolys BioPharma Inc. 161.1 Million JPY 33.675%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited 397 Million JPY 73.086%
Healios K.K. 450 Million JPY 76.256%
BrightPath Biotherapeutics Co., Ltd. - JPY -Infinity%
Kubota Pharmaceutical Holdings Co., Ltd. - JPY -Infinity%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 77.29 Million JPY -38.242%
FunPep Company Limited - JPY -Infinity%
Kringle Pharma, Inc. - JPY -Infinity%
Stella Pharma Corporation 773.29 Million JPY 86.183%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. - JPY -Infinity%
Cuorips Inc. - JPY -Infinity%
K Pharma,Inc. - JPY -Infinity%
Takara Bio Inc. 788 Million JPY 86.44%
ReproCELL Incorporated - JPY -Infinity%
PhoenixBio Co., Ltd. 491.35 Million JPY 78.254%
StemCell Institute Inc. 6.67 Million JPY -1500.494%
Japan Tissue Engineering Co., Ltd. - JPY -Infinity%
CellSeed Inc. 143.75 Million JPY 25.67%